2015 Fiscal Year Final Research Report
Akt-mTOR and Autophagy in Colitic Cancer
Project/Area Number |
25670570
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Digestive surgery
|
Research Institution | The University of Tokyo |
Principal Investigator |
NOZAWA HIROAKI 東京大学, 医学部附属病院, 講師 (80529173)
|
Co-Investigator(Kenkyū-buntansha) |
YAMAGUCHI Hironori 東京大学, 医学部附属病院, 登録研究員 (20376445)
SUNAMI Eiji 東京大学, 医学部附属病院, 登録研究員 (70345205)
WATANABE Toshiaki 東京大学, 医学部附属病院, 教授 (80210920)
|
Project Period (FY) |
2013-04-01 – 2016-03-31
|
Keywords | colitic cancer / 炎症性腸疾患 / 発癌 / mTOR |
Outline of Final Research Achievements |
In mouse models for colitic cancer using azoxymethan (AOM) and dextran sodium sulfate (DSS), tumors developed mainly in the proximal colon. The expression level of 4E-BP1 was higher in tumors than normal mucosa by immunohistochemical study, which was confirmed by western blotting. However, the level of urine 8-OH-dG as a marker of oxidative stress was unchanged by AOM and/or DSS treatment. The association between colitic cancer and Akt-mTOR signaling axis should be elucidated by more extensive experiments.
|
Free Research Field |
大腸肛門病学
|